| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinicopathological retrospective study of 131 patients with primary bone lymphoma: a population-based study of successively treated cohorts from the British Columbia Cancer Agency
|
Ramadan, K.M.
|
|
|
18 |
1 |
p. 129-135
|
artikel
|
| 2 |
A hitherto unreported high incidence of zoledronic acid-induced acute phase reaction in patients with cancer treatment-induced bone loss
|
Santini, D.
|
|
|
18 |
1 |
p. 201-202
|
artikel
|
| 3 |
Alcohol consumption and risk of Hodgkin's lymphoma and multiple myeloma: a multicentre case–control study
|
Gorini, G.
|
|
|
18 |
1 |
p. 143-148
|
artikel
|
| 4 |
A phase II study of bortezomib in mantle cell lymphoma: the National Cancer Institute of Canada Clinical Trials Group trial IND.150
|
Belch, A.
|
|
|
18 |
1 |
p. 116-121
|
artikel
|
| 5 |
Artificial sweeteners and cancer risk in a network of case–control studies
|
Gallus, S.
|
|
|
18 |
1 |
p. 40-44
|
artikel
|
| 6 |
Association of CXCR4 and CCR7 chemokine receptor expression and lymph node metastasis in human cervical cancer
|
Kodama, J.
|
|
|
18 |
1 |
p. 70-76
|
artikel
|
| 7 |
Clinical benefit of fulvestrant in postmenopausal women with advanced breast cancer and primary or acquired resistance to aromatase inhibitors: final results of phase II Swiss Group for Clinical Cancer Research Trial (SAKK 21/00)
|
Perey, L.
|
|
|
18 |
1 |
p. 64-69
|
artikel
|
| 8 |
Clinicopathological features of pyothorax-associated lymphoma; a retrospective survey involving 98 patients
|
Narimatsu, H.
|
|
|
18 |
1 |
p. 122-128
|
artikel
|
| 9 |
Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature
|
Delea, T.E.
|
|
|
18 |
1 |
p. 197-198
|
artikel
|
| 10 |
Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer
|
Lin, C.-C.
|
|
|
18 |
1 |
p. 93-98
|
artikel
|
| 11 |
Concurrent radiotherapy and capecitabine, followed by high-dose methotrexate consolidation, provided effective palliation in a patient with leptomeningeal metastases from breast cancer
|
Carmona-Bayonas, A.
|
|
|
18 |
1 |
p. 199-200
|
artikel
|
| 12 |
Diarrhea in neutropenic patients: a prospective cohort study with emphasis on neutropenic enterocolitis
|
Aksoy, D.Y.
|
|
|
18 |
1 |
p. 183-189
|
artikel
|
| 13 |
Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study
|
Piedbois, P.
|
|
|
18 |
1 |
p. 52-57
|
artikel
|
| 14 |
EGFR and KRAS mutations as criteria for treatment with tyrosine kinase inhibitors: retro- and prospective observations in non-small-cell lung cancer
|
van Zandwijk, N.
|
|
|
18 |
1 |
p. 99-103
|
artikel
|
| 15 |
EGFR mutations in exons 18–21 in sporadic breast cancer
|
Generali, D.
|
|
|
18 |
1 |
p. 203-205
|
artikel
|
| 16 |
Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology
|
Ou, S.-H.I
|
|
|
18 |
1 |
p. 29-35
|
artikel
|
| 17 |
EUROCARE study underestimated the curability of breast cancer in Poland
|
Bębenek, M.
|
|
|
18 |
1 |
p. 200-201
|
artikel
|
| 18 |
Extramedullary disease and targeted therapies for hematological malignancies—is the association real?
|
Raanani, P.
|
|
|
18 |
1 |
p. 7-12
|
artikel
|
| 19 |
Fried foods, olive oil and colorectal cancer
|
Galeone, C.
|
|
|
18 |
1 |
p. 36-39
|
artikel
|
| 20 |
Gemcitabine, oxaliplatin and weekly high-dose 5-FU as 24-h infusion in chemonaive patients with advanced or metastatic pancreatic adenocarcinoma: a multicenter phase II trial of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
|
Wagner, A.D.
|
|
|
18 |
1 |
p. 82-87
|
artikel
|
| 21 |
Health-related quality of life in disease-free survivors of breast cancer with the general population
|
Ahn, S.H.
|
|
|
18 |
1 |
p. 173-182
|
artikel
|
| 22 |
Henoch–Schönlein purpura (HSP) during treatment with anastrozole
|
Conti-Beltraminelli, M.
|
|
|
18 |
1 |
p. 205-207
|
artikel
|
| 23 |
High-dose chemotherapy for triple negative breast cancer
|
De Giorgi, U.
|
|
|
18 |
1 |
p. 202-203
|
artikel
|
| 24 |
Incidence and risk factors of central nervous system recurrence in aggressive lymphoma—a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin's Lymphoma Study Group (DSHNHL)
|
Boehme, V.
|
|
|
18 |
1 |
p. 149-157
|
artikel
|
| 25 |
Initial chemotherapy with mitoxantrone, chlorambucil, prednisone impairs the collection of stem cells in patients with indolent lymphomas—results of a randomized comparison by the German Low-Grade Lymphoma Study Group
|
Nickenig, C.
|
|
|
18 |
1 |
p. 136-142
|
artikel
|
| 26 |
Interferon-α and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?
|
Fazio, N.
|
|
|
18 |
1 |
p. 13-19
|
artikel
|
| 27 |
in this issue
|
|
|
|
18 |
1 |
p. 1
|
artikel
|
| 28 |
IQ in early adulthood and later cancer risk: cohort study of one million Swedish men
|
Batty, G.D.
|
|
|
18 |
1 |
p. 21-28
|
artikel
|
| 29 |
It is too early to know if intelligence determines cancer incidence and survival
|
Aapro, M.S.
|
|
|
18 |
1 |
p. 4-5
|
artikel
|
| 30 |
Late risk of relapse and mortality among postmenopausal women with estrogen responsive early breast cancer after 5 years of tamoxifen
|
Kennecke, H.F.
|
|
|
18 |
1 |
p. 45-51
|
artikel
|
| 31 |
MR-guided focused ultrasound surgery (MRgFUS) for the palliation of pain in patients with bone metastases—preliminary clinical experience
|
Catane, R.
|
|
|
18 |
1 |
p. 163-167
|
artikel
|
| 32 |
Now the New Year reviving old desires
|
Kerr, D.J.
|
|
|
18 |
1 |
p. 3
|
artikel
|
| 33 |
Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone
|
Mani, S.
|
|
|
18 |
1 |
p. 190-195
|
artikel
|
| 34 |
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study
|
André, T.
|
|
|
18 |
1 |
p. 77-81
|
artikel
|
| 35 |
Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma
|
Lee, J.
|
|
|
18 |
1 |
p. 88-92
|
artikel
|
| 36 |
Randomised phase II study comparing topotecan/carboplatin administration for 5 versus 3 days in the treatment of extensive-stage small-cell lung cancer
|
Seifart, U.
|
|
|
18 |
1 |
p. 104-109
|
artikel
|
| 37 |
Randomized phase II trial of gemcitabine plus weekly versus three-weekly paclitaxel in previously untreated advanced non-small-cell lung cancer
|
Belani, C.P.
|
|
|
18 |
1 |
p. 110-115
|
artikel
|
| 38 |
Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study
|
Alexandre, J.
|
|
|
18 |
1 |
p. 168-172
|
artikel
|
| 39 |
Reply to ‘Conclusions regarding relative cost–utility of alternative strategies for use of aromatase inhibitors in postmenopausal women with early breast cancer are premature’ by Delea et al.
|
Lonning, E.
|
|
|
18 |
1 |
p. 198-199
|
artikel
|
| 40 |
Table of Contents
|
|
|
|
18 |
1 |
p. iv-vi
|
artikel
|
| 41 |
Twice-daily pain monitoring as standard clinical practice for inpatients at a medical oncology unit: a descriptive study
|
Martoni, A.A.
|
|
|
18 |
1 |
p. 158-162
|
artikel
|
| 42 |
Which benefit from adding gemcitabine to vinorelbine in elderly (≥70 years) women with metastatic breast cancer? Early interruption of a phase II study
|
Basso, U.
|
|
|
18 |
1 |
p. 58-63
|
artikel
|
Tijdschrift beschrijving